10 July 2025
The ITA reports that the Player Ahmed Jalal Abbas Mansoor Fadhul has agreed¹ to the consequences imposed for his anti-doping rule violation (ADRV).
The Player provided a sample on 23 January 2024 during an in-competition anti-doping control at the 2024 Asian Men’s Handball Championship. After analysis by a World Anti-Doping Agency (WADA)-accredited laboratory, the sample returned an adverse analytical finding for 5-methylhexan-2-amine (1,4-dimethylpentylamine).²
5-methylhexan-2-amine (1,4-dimethylpentylamine) is prohibited under the WADA Prohibited List as S6. Stimulants. It is prohibited in-competition only and is classified as a specified substance. This substance may improve concentration and alertness by increasing energy levels and endurance, and accelerating the metabolism.
The Player did not challenge the ADRV and agreed with the consequences proposed by the ITA, namely a period of ineligibility of two years from 23 January 2024 until 22 January 2026 and disqualification of his individual competitive results from 23 January 2024 onwards.
The parties’ respective deadlines to appeal the agreement on consequences before the appeals division of the Court of Arbitration for Sport have now expired; the agreement on consequences is considered as final.
The ITA will not comment further on this case.
¹ Players have the right to choose not to have their case referred to a hearing panel. In these instances, the anti-doping organisation will assess the Player’s case file and establish the applicable consequences pursuant to the anti-doping rules and the Player will have the right to accept the proposed consequences. If the Player refuses the proposed consequences, the case is transferred to a hearing panel. This resolution mechanism is provided for in articles 8.3.1 and 8.3.3 of the IHF anti-doping rules and 8.3 of the World Anti-Doping Code and is commonly referred to as an agreement on consequences and is deemed an IHF/ITA decision. The Player’s National Anti-Doping Organisation and the World Anti-Doping Agency have the right to appeal the agreement on consequences before the competent appeal body.
² A report from a WADA-accredited laboratory that, consistent with the International Standard for Laboratories, establishes in a sample the presence of a prohibited substance or its metabolites or markers or evidence of the use of a prohibited method.